Feng Bai, Jun Pu, Wenliang Che, Jiyan Chen, Mao Chen, Wei Chen, Xiaoping Chen, Yundai Chen, Xianwu Cheng, Xiang Cheng, Hongliang Cong, Cuilian Dai, Dali Fan, Guosheng Fu, Lei Gao, Chuanyu Gao, Wei Gao, Junbo Ge, Ben He, Tao Hu, Congxin Huang, Jing Huang, Yong Huo, Shaobin Jia, Jun Jiang, Zhicheng Jing, Xiangqing Kong, Lang Li, Yan Li, Yigang Li, Zhijuan Li, Chun Liang, Xianhe Lin, Xianxia Liu, Xuebo Liu, Chengzhi Lu, Genshan Ma, Yitong Ma, Wei Mao, Xia Mei, Zhongping Ning, Jiafu Ou, Shaderdin Slaj, Chengxing Shen, Haiming Shi, Hong Shi, Bei Shi, Xi Su, Ningling Sun, Qizhu Tang, Fang Wang, Changqian Wang, Jin Wang, Yanqing Wu, Yongjian Wu, Yunlong Xia, Dingcheng Xiang, Pingxi Xiao, Ping Xie, Dingding Xiong, Yawei Xu, Jiefu Yang, Lixia Yang, Zaixin Yu, Zuyi Yuan, Haitao Yuan, Guogang Zhang, Heng Zhang, Jian Zhang, Li Zhang, Ruiyan Zhang, Shuning Zhang, Shuyang Zhang, Zheng Zhang, Guoan Zhao, Xianxian Zhao, Jingang Zheng, Haoyi Zheng, Daxin Zhou, Shenghua Zhou, Yujie Zhou
{"title":"2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases.","authors":"Feng Bai, Jun Pu, Wenliang Che, Jiyan Chen, Mao Chen, Wei Chen, Xiaoping Chen, Yundai Chen, Xianwu Cheng, Xiang Cheng, Hongliang Cong, Cuilian Dai, Dali Fan, Guosheng Fu, Lei Gao, Chuanyu Gao, Wei Gao, Junbo Ge, Ben He, Tao Hu, Congxin Huang, Jing Huang, Yong Huo, Shaobin Jia, Jun Jiang, Zhicheng Jing, Xiangqing Kong, Lang Li, Yan Li, Yigang Li, Zhijuan Li, Chun Liang, Xianhe Lin, Xianxia Liu, Xuebo Liu, Chengzhi Lu, Genshan Ma, Yitong Ma, Wei Mao, Xia Mei, Zhongping Ning, Jiafu Ou, Shaderdin Slaj, Chengxing Shen, Haiming Shi, Hong Shi, Bei Shi, Xi Su, Ningling Sun, Qizhu Tang, Fang Wang, Changqian Wang, Jin Wang, Yanqing Wu, Yongjian Wu, Yunlong Xia, Dingcheng Xiang, Pingxi Xiao, Ping Xie, Dingding Xiong, Yawei Xu, Jiefu Yang, Lixia Yang, Zaixin Yu, Zuyi Yuan, Haitao Yuan, Guogang Zhang, Heng Zhang, Jian Zhang, Li Zhang, Ruiyan Zhang, Shuning Zhang, Shuyang Zhang, Zheng Zhang, Guoan Zhao, Xianxian Zhao, Jingang Zheng, Haoyi Zheng, Daxin Zhou, Shenghua Zhou, Yujie Zhou","doi":"10.1097/CP9.0000000000000043","DOIUrl":null,"url":null,"abstract":"<p><p>The primary site of infection in COVID-19 exhibit is the respiratory system, but multiple organ systems could be affected. The virus could directly invade cardiomyocytes. Alternatively, cytokine storm could lead to myocardial injury. More importantly, the management of existing cardiovascular diseases must be re-examined in COVID-19 due to, for example, interaction between antiviral agents and with a wide variety of pharmacological agents. The Branch of Cardiovascular Physicians of Chinese Medical Doctor Association organized a panel of experts in cardiovascular and related fields to discuss this important issue, and formulated the \"2023 Chinese Expert Consensus on the Impact of COVID-19 on the Management of Cardiovascular Diseases.\" The Consensus was drafted on the basis of systematic review of existing evidence and diagnosis and treatment experience, and covers three major aspects: myocardial injury caused by COVID-10 and COVID-19 vaccine, the impact of COVID-19 on patients with cardiovascular disease, and the impact of COVID-19 on the cardiovascular system of healthy people, and rehabilitation guidance recommendations. The Consensus involves 11 core clinical issues, including incidence, pathogenesis, clinical manifestations, treatment strategies, prognosis, and rehabilitation. It is our hope that this Consensus will provide a practical guidance to cardiologists in the management of cardiovascular diseases in the new era of COVID-19 pandemic.</p>","PeriodicalId":52908,"journal":{"name":"Cardiology Plus","volume":"8 2","pages":"82-102"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0b/59/cp9-8-082.PMC10358441.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology Plus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CP9.0000000000000043","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
The primary site of infection in COVID-19 exhibit is the respiratory system, but multiple organ systems could be affected. The virus could directly invade cardiomyocytes. Alternatively, cytokine storm could lead to myocardial injury. More importantly, the management of existing cardiovascular diseases must be re-examined in COVID-19 due to, for example, interaction between antiviral agents and with a wide variety of pharmacological agents. The Branch of Cardiovascular Physicians of Chinese Medical Doctor Association organized a panel of experts in cardiovascular and related fields to discuss this important issue, and formulated the "2023 Chinese Expert Consensus on the Impact of COVID-19 on the Management of Cardiovascular Diseases." The Consensus was drafted on the basis of systematic review of existing evidence and diagnosis and treatment experience, and covers three major aspects: myocardial injury caused by COVID-10 and COVID-19 vaccine, the impact of COVID-19 on patients with cardiovascular disease, and the impact of COVID-19 on the cardiovascular system of healthy people, and rehabilitation guidance recommendations. The Consensus involves 11 core clinical issues, including incidence, pathogenesis, clinical manifestations, treatment strategies, prognosis, and rehabilitation. It is our hope that this Consensus will provide a practical guidance to cardiologists in the management of cardiovascular diseases in the new era of COVID-19 pandemic.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
